Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.
- DOI
- 10.1016/j.xops.2024.100492
- Published
- 2024 Jul-Aug
- Container
- Ophthalmology science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xops.2024.100492,
title = {Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.},
author = {Dohlman TH and Singh RB and Amparo F and Carreno-Galeano T and Dastjerdi M and Coco G and Di Zazzo A and Shikari H and Saboo U and Sippel K and Ciralsky J and Yoo SH and Sticca M and Wakamatsu TH and Murthy S and Hamrah P and Jurkunas U and Ciolino JB and Saeed H and Gomes JAP and Perez VL and Yin J and Dana R},
year = {2024},
journal = {Ophthalmology science},
doi = {10.1016/j.xops.2024.100492},
url = {https://doi.org/10.1016/j.xops.2024.100492}
}RIS
TY - JOUR TI - Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation. AU - Dohlman TH AU - Singh RB AU - Amparo F AU - Carreno-Galeano T AU - Dastjerdi M AU - Coco G AU - Di Zazzo A AU - Shikari H AU - Saboo U AU - Sippel K AU - Ciralsky J AU - Yoo SH AU - Sticca M AU - Wakamatsu TH AU - Murthy S AU - Hamrah P AU - Jurkunas U AU - Ciolino JB AU - Saeed H AU - Gomes JAP AU - Perez VL AU - Yin J AU - Dana R PY - 2024 JO - Ophthalmology science DO - 10.1016/j.xops.2024.100492 UR - https://doi.org/10.1016/j.xops.2024.100492 ER -
APA
TH, D., RB, S., F, A., T, C., M, D., G, C., A, D. Z., H, S., U, S., K, S., J, C., SH, Y., M, S., TH, W., S, M., P, H., U, J., JB, C., H, S., JAP, G., VL, P., J, Y., & R, D. (2024). Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.. Ophthalmology science. https://doi.org/10.1016/j.xops.2024.100492
Source records
- pubmed · retrieved 2026-09-26T11:24:05.163Z